Pablo Zubiaur

40PUBLICATIONS
109CO-AUTHORS
PharmacogenomicsReaction engineering (excl. nuclear reactions)Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Apr 17, 2026
PharmVar GeneFocus: CYP1A2-Clinical Impact, Genetic Variation, and Updated Nomenclature.

|Mar 03, 2026
Role of Pharmacogenetics on Tramadol Pharmacokinetics: A Population Pharmacokinetic Model.

Paula Soria-Chacartegui, Gudrun Würthwein, Pablo Zubiaur

|Sep 20, 2025
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy.

Michael T Eadon, David W Hein, Michael A Andersen

|Jul 30, 2025
Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study.

Noelia Pérez-Gómez, Antonio Sanz-Solas, Beatriz Cuevas

|Apr 26, 2025
Impact of Genetic Variation in Adrenergic Receptors on β-Blocker Effectiveness and Safety in Cardiovascular Disease Management: A Systematic Review.

Houwaida Abbes, Paula Soria-Chacartegui, Asma Omezzine

|Mar 27, 2025
CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin.

Rubin Lubomirov, Laura Pérez-Ramos, Salvador Fudio

Pageof 7

Frequent Collaborators

34 joint publications

Francisco Abad-Santos

16 joint publications

Gonzalo Villapalos-García

15 joint publications

Gina Mejía-Abril

12 joint publications

Paula Soria-Chacartegui